Seymour M. Farber
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Seymour M. Farber.
Radiology | 1949
Seymour M. Farber; Mortimer A. Benioff; Allen K. McGrath
Attention has been focused recently upon the application of cytologic technics to the diagnosis of primary carcinoma of the lung. Experience with 100 cases of proved bronchogenic carcinoma has indicated that this technic has diagnostic value. The need for additional diagnostic aids in this disease has been emphasized in reported series (1, 2, 3, 4, 5) in which as high as 50 per cent of the cases were not recognized prior to autopsy. As early as 1887 Hampeln was able to diagnose carcinoma of the lung by examination of unstained microscopic particles of expectorated malignant tissue. Other early workers also reported the diagnosis of cancer of the lung by finding bizarre cells in sputum examined by such simple methods. More recent investigators have blocked and sectioned sputum, using ordinary histologic technics, and some have reported good results (6, 7). The development of wet-film technics has simplified the cytologic study of sputum and bronchial secretions and has led to more widespread use of this di...
The American Journal of Medicine | 1957
Seymour M. Farber; Roger H. L. Wilson; Orville F. Grimes
Abstract The initial enthusiasm with which enzyme therapy was greeted must now be tempered with caution. Although excellent results have been obtained with application of various enzymes in diseases of the chest, toxic manifestations both immediate and delayed have become numerous enough to give us pause in the routine use of these agents. The main problems to be resolved in enzyme therapy appear to be the following: 1.1. Enzymes used clinically at present are derived from non-human sources and are applied to sites in which such substances would not normally occur. They may give rise to antibody formation with occasional marked hypersensitivity causing severe local and systemic disturbances. 2.2. The enzymes themselves or the products of lysis produce local and systemic reactions of varying severity in almost all patients, depending upon dosage and route of administration. 3.3. Late toxic effects upon epithelium have been seen in the tracheobronchial tree. 4.4. The dissolution of fibrin plugging a bronchopleural fistula or a vessel gives rise not infrequently to hydropneumothorax or severe hemorrhage. Prediction of success or complication in the therapeutic application of enzymes is not now possible. Serious complications may occur early and it is necessary carefully to calculate the risks when enzyme therapy is proposed. This is not to suggest that enzyme therapy should only rarely be employed, but to emphasize the powerful nature of these agents and the dangers in their indiscriminate use.
Oral Surgery, Oral Medicine, Oral Pathology | 1952
Seymour M. Farber
Some people may be laughing when looking at you reading in your spare time. Some may be admired of you. And some may want be like you who have reading hobby. What about your own feel? Have you felt right? Reading is a need and a hobby at once. This condition is the on that will make you feel that you must read. If you know are looking for the book enPDFd cancer respiratory system as the choice of reading, you can find here.
Annals of the New York Academy of Sciences | 1967
Seymour M. Farber
To deny the importance of biomedical communication at a gathering such as this would be tantamount to contesting the primacy of virtue over vice. In fact, I agree that biomedical communication is essential to the health sciences, that it ought to be improved, and that there is good reason for concern over present inadequate dissemination of medical information. But I believe that our concern should include the type of information we communicate, as well as our methods of communication. My point is that “hard” technical data is a necessary but insufficient prerequisite to achieving and maintaining the highest possible standard of medical practice. There is also a need for national concern about biomedical communication in a broader and indispensable sense which is seriously lacking today. However, before this other aspect of health information is examined, I would like to discuss some features of the communication problem as it is ordinarily considered.
Annals of Internal Medicine | 1959
Seymour M. Farber; Roger H. L. Wilson
Excerpt Pharmacologic bronchodilators have been used perhaps as long as any known medicinal agent. The use of ephedrine (ma hwang) is shrouded in the mists of Chinese antiquity. The burning of stra...
Journal of Dental Research | 1958
Sol Silverman; Hermann Becks; Seymour M. Farber
Chest | 1948
Seymour M. Farber; Mortimer A. Benioff; John K. Frost; Milton Rosenthal; Gerd Tobias
Chest | 1951
Seymour M. Farber; Allen K. McGRATH; Mortimer A. Benioff; Lloyd W. Espen
Chest | 1957
Seymour M. Farber; David A. Wood; Samuel L. Pharr; Bernard Pierson
Chest | 1954
Seymour M. Farber